EcoDrugPlus

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSCMIG00000019979
Gene Symbol: IMPDH2
3 Cross references
202 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1

Ensembl ID : ENSCMIG00000004942
Gene Symbol: LOC103190184
3 Cross references
335 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSCMIG00000010316
Gene Symbol: INPP5D
4 Cross references
266 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCMIG00000008201
Gene Symbol: IGF1R
4 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSCMIG00000004667
Gene Symbol: INSR
4 Cross references
291 Possible Orthologues:

Integrin Alpha-8-Like

Ensembl ID : ENSCMIG00000008802
Gene Symbol: LOC103183860
2 Cross references
191 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSCMIG00000009686
Gene Symbol: LOC103188813
2 Cross references
325 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCMIG00000014261
Gene Symbol: ITGA4
3 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCMIG00000014617
Gene Symbol: ITGAV
3 Cross references
244 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSCMIG00000009793
Gene Symbol: ITGB1
4 Cross references
325 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSCMIG00000009240
Gene Symbol: ITGB3
3 Cross references
269 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCMIG00000008931
Gene Symbol: ITGB5
3 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).